Standard Hospice Morphine Orders
For hospice pain management, start with oral morphine immediate-release (IR) 15-30 mg every 4 hours scheduled, with the same dose available every hour as needed for breakthrough pain, then titrate daily based on total rescue doses used. 1, 2
Initial Dosing Strategy
Opioid-Naive Patients
- Begin with morphine IR 15-30 mg orally every 4 hours around-the-clock 1, 2
- For patients over 70 years old, consider starting at 10 mg every 4 hours 3
- Provide the same dose (15-30 mg) for breakthrough pain, available as often as every hour 1, 4
Dose Titration Protocol
- Review total morphine consumption after 24 hours (scheduled doses + all breakthrough doses) 4
- Increase the regular scheduled dose based on breakthrough dose frequency: if patient required multiple rescue doses, add them to calculate new total daily dose and redistribute 1
- Continue this daily assessment until pain is controlled 1
Transition to Long-Acting Formulations
Converting to Extended-Release (ER) Morphine
- Once dose is stable on IR morphine, convert to ER morphine by dividing total daily dose by 2 for twice-daily dosing 4
- Breakthrough dose = one-third of the 12-hour ER dose (equivalent to the 4-hourly IR dose) 1, 4
- Example: For 120 mg total daily dose → morphine ER 60 mg every 12 hours + morphine IR 20 mg every hour as needed 4
Bedtime Dosing Adjustment
- For patients on IR morphine every 4 hours, give double dose at bedtime to prevent nighttime awakening from pain 1, 4
- This practice is widely adopted and effective without causing adverse effects 1
Alternative Routes When Oral Route Unavailable
Route Selection Priority
- First alternative: Rectal administration (same bioavailability as oral, 1:1 potency ratio) 1, 5
- Second alternative: Subcutaneous administration (either bolus every 4 hours or continuous infusion) 1
- Avoid intramuscular route - subcutaneous is simpler and less painful 1
Conversion Ratios for Route Changes
- Oral to subcutaneous: 1:2 ratio (divide oral dose by 2) 1
- Oral to intravenous: 1:3 ratio (divide oral dose by 3) 1, 2
- Oral to rectal: 1:1 ratio (same dose) 1, 5
Parenteral Dosing
- Subcutaneous morphine starting dose: 5-10 mg every 4 hours 1
- Intravenous morphine starting dose: 5-10 mg 1
- For severe pain requiring urgent relief, use parenteral route initially then convert to oral 1
Critical Safety Considerations
Formulation Warnings
- Never crush controlled-release/ER morphine tablets - this destroys the extended-release mechanism causing dose dumping, respiratory depression, and potential death 1, 5
- Do not use ER tablets rectally or vaginally 1, 5
Monitoring Requirements
- Monitor closely for respiratory depression, especially in first 24-72 hours after initiation or dose increases 2
- Assess for constipation and prescribe prophylactic laxatives routinely 4
- Initial drowsiness, dizziness, or mental clouding typically resolves within days 4
Common Pitfalls to Avoid
Dosing Errors
- Do not use smaller breakthrough doses than recommended - the full dose (equal to regular 4-hour dose) is more effective and dose-related adverse effects are insignificant 4
- Do not increase dosing frequency beyond every 4 hours for IR or every 12 hours for ER - this complicates the regimen without benefit 1, 4
- If pain returns before next scheduled dose, increase the dose amount, not the frequency 1
Special Circumstances
- Some patients may require ER morphine every 8 hours instead of every 12 hours if adequate analgesia duration is not achieved 1, 4
- For patients with poor peripheral circulation, generalized edema, coagulation disorders, or erythema at injection sites, subcutaneous route may not be practical 1
- Consider alternative opioids (diamorphine in UK, hydromorphone elsewhere) for parenteral use due to greater solubility 1
Dose Range Expectations
Typical Dosing
- Most patients achieve adequate pain control with oral morphine 30 mg or less every 4 hours 6
- Effective doses range from as little as 2.4 mg to over 100 mg every 4 hours 6
- At 4 weeks, mean dose typically remains around 45 mg daily for opioid-naive patients started on low doses 3
High-Dose Morphine
- High-dose morphine (≥300 mg/day) is required in approximately 9-12% of hospice patients 7, 8
- Younger patients, males, and those with bone metastases, GI/lung primaries, or spinal disease more commonly require higher doses 7, 8
- High-dose morphine does not adversely affect survival and should not be a barrier to adequate pain control 7, 8
- No upper dose limit exists - maximum dose depends on tolerance development 1